IndraLab

Statements


| 8

reach
"A recent publication demonstrated that a ubiquitin variant, engineered to bind tightly to USP7, inhibits USP7 selectively ( K D , 56 nM)."

reach
"Here we report PROTACs based on a ubiquitin-specific protease 7 (USP7) inhibitor scaffold to degrade USP7."

reach
"Our result indicated the promotion of TRIP12 expression by TSPY1, providing a clue for investigating the potential mechanism underlying ubiquitin mediated degradation of USP7 in future studies."

reach
"Moreover, our experiments showed that TSPY1 could decrease the p53 level by facilitating ubiquitin mediated USP7 degradation."

reach
"A ubiquitin variant expressed in human tumor cell lines binds and inhibits endogenous USP7, thereby enhancing Mdm2 proteasomal turnover and stabilizing p53."

reach
"Another promising approach to stabilizing p53 in cancer cells consists of promoting the MDM2 proteasomal degradation through the Ub variant (UbV)-mediated inhibition of USP7 and USP2a deubiquitinases, known to be involved in stabilizing MDM2."

reach
"TSPY1 induces ubiquitin dependent degradation of USP7."

reach
"Because USP7 could stabilize most of the proteins degraded in extract treated with UbVS and ubiquitin, we tested if inactivation of USP7 using the specific inhibitor XL-188 was sufficient to induce degradation of the substrates that we identified."